ADROIT

What is the Purpose of this Study?

This data collection study focuses on individuals who are scheduled to receive an Abbott Deep Brain Stimulation (DBS) systems implant to help treat their movement disorder. DBS therapy uses small electrical pulses at a specific area within the brain to treat movement disorder. It requires an operation to place thin wires with electrodes in the brain and to connect the electrodes to a battery. The implanted system includes an implantable pulse generator (IPG) that holds the battery and electrical components that generate the stimulation pulses; a thin wire with electrodes; and an extension that carries the stimulation pulses from the IPG to the electrodes. The Abbott DBS systems used in this study have been approved by the Food and Drug Administration (FDA). The study will allow Abbott to continue to monitor the approved devices for a period of up to five years.


Eligibility

  • 1. Subject is scheduled for a new implant or IPG device replacement surgery with a market-released Abbott DBS system within 180 days.
  • 2. Subject, or a legally acceptable representative, must provide written informed consent prior to any study-related procedure.
Show more

Where can I participate?

Beverly

More about this Clinical Trial

What is the full name of this clinical trial?

Abbott DBS Registry of Outcomes for Indications over Time

Study Details
Disease Type/Condition

Movement Disorders

Principal Investigator

Tan, Echo

Co-Investigators

Elliot Hogg, Michele Tagliati

Age Group

Both

Phase

N/A

IRB Number

STUDY00000625

ClinicalTrials.gov ID

NCT04071847

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Movement Disorders

Principal Investigator

Tan, Echo

Age Group

Both

Phase

N/A

IRB Number

ABT-CIP-10300

ClinicalTrials.gov ID

NCT04071847

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org